Psoriasis

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

Psoriasis Longitudinal Assessment and Registry

A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Psoriasis Comorbidities at Hospital Calderón Guardia

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics

Deucravacitinib Adherence Study

A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps

Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis

Multi-Center PAMPA Study

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

An AI-Based Erythema Measurement System for Psoriasis Lesions

Impact of Clinical and Psychological Factors on Satisfaction With Treatment in Psoriatic Patients on Biological Therapy